These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 29393868)

  • 1. Galectin-3: The Impact on the Clinical Management of Patients with Thyroid Nodules and Future Perspectives.
    Bartolazzi A; Sciacchitano S; D'Alessandria C
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Chimeric Antigen-Binding Fragment Directed Against Human Galectin-3 and Validation as an Immuno-Positron Emission Tomography Tracer for the Sensitive
    Peplau E; De Rose F; Reder S; Mittelhäuser M; Scafetta G; Schwaiger M; Weber WA; Bartolazzi A; Skerra A; D'Alessandria C
    Thyroid; 2020 Sep; 30(9):1314-1326. PubMed ID: 32200708
    [No Abstract]   [Full Text] [Related]  

  • 3. Galectin-3 Targeting in Thyroid Orthotopic Tumors Opens New Ways to Characterize Thyroid Cancer.
    De Rose F; Braeuer M; Braesch-Andersen S; Otto AM; Steiger K; Reder S; Mall S; Nekolla S; Schwaiger M; Weber WA; Bartolazzi A; D'Alessandria C
    J Nucl Med; 2019 Jun; 60(6):770-776. PubMed ID: 30361380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodology and technical requirements of the galectin-3 test for the preoperative characterization of thyroid nodules.
    Bartolazzi A; Bellotti C; Sciacchitano S
    Appl Immunohistochem Mol Morphol; 2012 Jan; 20(1):2-7. PubMed ID: 21691201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-1 is a diagnostic marker involved in thyroid cancer progression.
    Arcolia V; Journe F; Wattier A; Leteurtre E; Renaud F; Gabius HJ; Remmelink M; Decaestecker C; Rodriguez A; Boutry S; Laurent S; Saussez S
    Int J Oncol; 2017 Sep; 51(3):760-770. PubMed ID: 28677745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive In Vivo Imaging and Biologic Characterization of Thyroid Tumors by ImmunoPET Targeting of Galectin-3.
    D'Alessandria C; Braesch-Andersen S; Bejo K; Reder S; Blechert B; Schwaiger M; Bartolazzi A
    Cancer Res; 2016 Jun; 76(12):3583-92. PubMed ID: 27216181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant risk stratification of thyroid FNA specimens with indeterminate cytology based on molecular testing.
    Paskaš S; Janković J; Živaljević V; Tatić S; Božić V; Nikolić A; Radojković D; Savin S; Cvejić D
    Cancer Cytopathol; 2015 Aug; 123(8):471-9. PubMed ID: 25924719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity.
    André S; Kojima S; Yamazaki N; Fink C; Kaltner H; Kayser K; Gabius HJ
    J Cancer Res Clin Oncol; 1999; 125(8-9):461-74. PubMed ID: 10480338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin expression in cancer diagnosis and prognosis: A systematic review.
    Thijssen VL; Heusschen R; Caers J; Griffioen AW
    Biochim Biophys Acta; 2015 Apr; 1855(2):235-47. PubMed ID: 25819524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum galectin-1 and galectin-3 levels in benign and malignant nodular thyroid disease.
    Saussez S; Glinoer D; Chantrain G; Pattou F; Carnaille B; André S; Gabius HJ; Laurent G
    Thyroid; 2008 Jul; 18(7):705-12. PubMed ID: 18630998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Galectins in Tumors and in Clinical Immunotherapy.
    Chou FC; Chen HY; Kuo CC; Sytwu HK
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined staining for immunohistochemical markers in the diagnosis of papillary thyroid carcinoma: improvement in the sensitivity or specificity?
    Wu G; Wang J; Zhou Z; Li T; Tang F
    J Int Med Res; 2013 Aug; 41(4):975-83. PubMed ID: 23857157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.
    Bartolazzi A; Orlandi F; Saggiorato E; Volante M; Arecco F; Rossetto R; Palestini N; Ghigo E; Papotti M; Bussolati G; Martegani MP; Pantellini F; Carpi A; Giovagnoli MR; Monti S; Toscano V; Sciacchitano S; Pennelli GM; Mian C; Pelizzo MR; Rugge M; Troncone G; Palombini L; Chiappetta G; Botti G; Vecchione A; Bellocco R;
    Lancet Oncol; 2008 Jun; 9(6):543-9. PubMed ID: 18495537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of galectin-3 in the pathogenesis of bladder transitional cell carcinoma.
    Zeinali M; Adelinik A; Papian S; Khorramdelazad H; Abedinzadeh M
    Hum Immunol; 2015 Oct; 76(10):770-4. PubMed ID: 26429330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor.
    Nagy N; Bronckart Y; Camby I; Legendre H; Lahm H; Kaltner H; Hadari Y; Van Ham P; Yeaton P; Pector JC; Zick Y; Salmon I; Danguy A; Kiss R; Gabius HJ
    Gut; 2002 Mar; 50(3):392-401. PubMed ID: 11839721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond immunohistochemistry and immunocytochemistry: a current perspective on galectin-3 and thyroid cancer.
    Li J; Vasilyeva E; Wiseman SM
    Expert Rev Anticancer Ther; 2019 Dec; 19(12):1017-1027. PubMed ID: 31757172
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnostic and prognostic role of HBME-1, galectin-3, and β-catenin in poorly differentiated and anaplastic thyroid carcinomas.
    Rossi ED; Straccia P; Palumbo M; Stigliano E; Revelli L; Lombardi CP; Santeusanio G; Pontecorvi A; Fadda G
    Appl Immunohistochem Mol Morphol; 2013 May; 21(3):237-41. PubMed ID: 23235344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assembly, organization and regulation of cell-surface receptors by lectin-glycan complexes.
    Elola MT; Blidner AG; Ferragut F; Bracalente C; Rabinovich GA
    Biochem J; 2015 Jul; 469(1):1-16. PubMed ID: 26173257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hexokinase III, cyclin A and galectin-3 are overexpressed in malignant follicular thyroid nodules.
    Hooft L; van der Veldt AA; Hoekstra OS; Boers M; Molthoff CF; van Diest PJ
    Clin Endocrinol (Oxf); 2008 Feb; 68(2):252-7. PubMed ID: 17868400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules.
    Gasbarri A; Martegani MP; Del Prete F; Lucante T; Natali PG; Bartolazzi A
    J Clin Oncol; 1999 Nov; 17(11):3494-502. PubMed ID: 10550147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.